UPDATE : Monday, September 7, 2020
상단여백
'Xolair’s reimbursement will change treatment paradigm for asthma patients' by Lee Han-soo 2020-07-09 18:11
Drugmakers appeal limited insurance benefit for dementia drug choline alfoscerate by Kim Chan-hyuk 2020-07-09 12:52
‘Hypertension drug Opsumit enhances right ventricle function’ by Shim Hyun-tai 2020-07-08 16:59
Crystal Genomics confirms safety of super-bacteria antibiotic candidate by Lee Han-soo 2020-07-08 16:58
‘Study results on MSD’s Keytruda very disappointing’ by Kim Yun-mi 2020-07-07 16:43
라인
ITC ruling gives Medytox upper hand in BTX strain dispute by Lee Han-soo 2020-07-07 11:47
Daewoong to conduct P1 trial of Covid-19 treatment in Indonesia by Lee Han-soo 2020-07-06 16:52
Regulator OKs Janssen's multiple myeloma treatment by Lee Han-soo 2020-07-06 15:48
Experts showed mixed preferences between 2 diabetes treatments by Kim Yun-mi 2020-07-06 14:20
[News Focus] Who will win BTX strain dispute – Daewoong or Medytox? by Kim Chan-hyuk 2020-07-06 11:50
라인
Crystal Genomics to start P2 trial of Covid-19 treatment by Lee Han-soo 2020-07-02 18:07
Boryung finds cancer drug has antiviral effect on Covid-19 by Shim Hyun-tai 2020-07-02 18:07
Heliximith unveiled how HX109 inhibits prostate hyperplasia by Lee Han-soo 2020-07-02 15:03
MSD Korea reshuffles personnel before spinoff of Organon by Kim Yun-mi 2020-07-02 13:44
Novartis’ asthma drug gets insurance benefit by Shim Hyun-tai 2020-07-01 20:05
라인
Takeda Korea completes takeover of Shire Korea by Lee Han-soo 2020-07-01 17:39
Hanmi to export dyslipidemia drug to Mexico via MSD by Shim Hyun-tai 2020-07-01 14:19
Hanmi's short bowel syndrome treatment wins rare pediatric disease status by Lee Han-soo 2020-06-30 17:38
Hugel submits NDA for BTX product in Europe by Lee Han-soo 2020-06-30 15:36
KPBMA to expand local drugmakers’ exchanges with Europe by Kim Chan hyuk 2020-06-30 14:09
여백
여백
여백
Back to Top